Back to top
more

Zurich Insurance Group (ZURVY)

(Delayed Data from OTC)

$35.57 USD

35.57
118,396

-0.18 (-0.50%)

Updated Aug 8, 2025 03:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (91 out of 244)

Industry: Insurance - Multi line

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

MURGY or ZURVY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

MURGY vs. ZURVY: Which Stock Is the Better Value Option?

Zacks Equity Research

AIZ vs. ZURVY: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

AIZ vs. ZURVY: Which Stock Is the Better Value Option?

Zacks Equity Research

AIZ or ZURVY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

AIZ vs. ZURVY: Which Stock Is the Better Value Option?

Zacks Equity Research

EG vs. ZURVY: Which Stock Is the Better Value Option?

by Zacks Equity Research

EG vs. ZURVY: Which Stock Is the Better Value Option?

Zacks Equity Research

EG or ZURVY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

EG vs. ZURVY: Which Stock Is the Better Value Option?

Zacks Equity Research

AXAHY or ZURVY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

AXAHY vs. ZURVY: Which Stock Is the Better Value Option?

Zacks Equity Research

AXAHY vs. ZURVY: Which Stock Is the Better Value Option?

by Zacks Equity Research

AXAHY vs. ZURVY: Which Stock Is the Better Value Option?

Zacks Equity Research

AXAHY or ZURVY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

AXAHY vs. ZURVY: Which Stock Is the Better Value Option?

Zacks Equity Research

AXAHY vs. ZURVY: Which Stock Is the Better Value Option?

by Zacks Equity Research

AXAHY vs. ZURVY: Which Stock Is the Better Value Option?

Zacks Equity Research

MURGY vs. ZURVY: Which Stock Is the Better Value Option?

by Zacks Equity Research

MURGY vs. ZURVY: Which Stock Is the Better Value Option?

Zacks Equity Research

AGESY vs. ZURVY: Which Stock Is the Better Value Option?

by Zacks Equity Research

AGESY vs. ZURVY: Which Stock Is the Better Value Option?

Zacks Equity Research

CRBG or ZURVY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

CRBG vs. ZURVY: Which Stock Is the Better Value Option?

Zacks Equity Research

Are Investors Undervaluing Prudential Financial (PRU) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Should Value Investors Buy Cigna (CI) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

ZURVY or PUK: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ZURVY vs. PUK: Which Stock Is the Better Value Option?

Zacks Equity Research

Should Value Investors Buy Allianz (ALIZY) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Should You Retain Selective Insurance (SIGI) in Your Portfolio?

by Zacks Equity Research

Selective Insurance (SIGI) is well-poised to gain from lower overhead and general and administrative expenses, strong new business growth, solid capital position and prudent capital deployment.

Zacks Equity Research

Horace Mann (HMN) Estimates Q2 Cat Loss, Trims 2022 Guidance

by Zacks Equity Research

Horace Mann's (HMN) lowered guidance for 2022 reflects estimated cat loss and equity market declines.

Zacks Equity Research

Radian (RDN) Boosts Mortgage Market Presence With New Unit

by Zacks Equity Research

Radian Group (RDN) introduces Radian Mortgage Capital LLC to expand market reach and boost its relationships across the mortgage ecosystem.

Zacks Equity Research

Why You Should Stay Invested in Arch Capital (ACGL) Stock

by Zacks Equity Research

Arch Capital (ACGL) remains poised to grow on business opportunities, rate increases and growth in existing accounts.

Tanuka De headshot

RLI Corporation (RLI) Up 10% in a Year: More Room to Run?

by Tanuka De

RLI Corporation (RLI) is poised to grow on a compelling portfolio, a focus on specialty insurance lines, an impressive record of underwriting profits and effective capital deployment.

Zacks Equity Research

Reasons Why Investors Should Retain EverQuote (EVER) Stock Now

by Zacks Equity Research

EverQuote (EVER) is poised to benefit from higher quote requests, the solid performance of automotive insurance providers and financial flexibility.

Zacks Equity Research

Here's Why Should You Stay Invested in Assurant (AIZ) Stock

by Zacks Equity Research

Strength in Global Lifestyle business, growth in fee-based capital-light businesses and solid capital management poise Assurant (AIZ) well for growth.

Zacks Equity Research

Here's Why Investing in MGIC Investment (MTG) is Prudent Now

by Zacks Equity Research

MGIC Investment (MTG) is poised to gain from a favorable loss reserve development, higher consolidated investment portfolio and investment yields and effective capital deployment.

Zacks Equity Research

Cognizant (CTSH) Inks Deal With Zurich Insurance Subsidiary

by Zacks Equity Research

Cognizant Technology Solutions (CTSH) has been selected as a strategic technology provider for Zurich Beteiligungs-AG to help in its digital transformation.